NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-081-2015-1-US-06 HUMAN BISPECIFIC EGFRVIII ANTIBODY ENGAGING MOLECULES US National Stage 14/406,161 9676858 Issued PDF
NIDCR E-036-2010-1-US-04 Compositions and Methods for Screening For Lyme Disease US DIV 14/562,068 9310367 Issued PDF
NIAID E-242-2014-0-PCT-02 ANTI-MALARIAL COMPOSITIONS PCT PCT PCT/US2014/068731 Expired
NIDCR E-485-2013-0-PCT-02 Methods of Treating or Preventing Pruritis by Blocking Natriuretic Polypeptide B PCT PCT PCT/US2014/068541 Expired
NCI E-269-2011-0-US-06 KITS FOR DETECTING AND MONITORING ENDOCRINE DISRUPTING CHEMICALS (EDCS) US National Stage 14/405,696 Abandoned
NIAID E-045-2015-0-US-01 NEUTRALIZING ANTIBODIES TO EBOLA VIRUS GLYCOPROTEIN AND THEIR USE US 62/087,087 Abandoned
NCI E-186-2007-2-US-07 Papillomavirus Pseudoviruses For Detection And Therapy Of Tumors US CON 14/558,301 10188751 Issued PDF
NCI E-087-2005-0-US-08 Custom Vectors For Treating And Preventing Pancreatic Cancer US CON 14/556,897 Abandoned
NIAAA E-060-2010-0-JP-01 Hydroxybutyrate Ester And Medical Use Thereof JP DIV 2014-241939 Issued
NCI E-136-2012-0-JP-04 High-Affinity Monoclonal Antibodies To Glypican-3 And Use Thereof JP National Stage 2015-515243 Issued
NCI E-184-2009-0-JP-13 COMBINATION IMMUNOTHERAPY COMPOSITIONS AGAINST CANCER AND METHODS JP DIV 2014-240182 Abandoned
NCI E-230-2011-1-LI-17 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use LI EP 13720737.9 Issued
NCI E-230-2011-1-IE-15 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use IE EP 13720737.9 Issued
NCI E-230-2011-1-IT-16 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use IT EP 13720737.9 Issued
NCI E-230-2011-1-DE-10 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use DE EP 13720737.9 Issued
NCI E-230-2011-1-FR-13 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use FR EP 13720737.9 Issued
NCI E-230-2011-1-DK-11 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use DK EP 13720737.9 Issued
NCI E-230-2011-1-BE-08 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use BE EP 13720737.9 Issued
NCI E-230-2011-1-PT-19 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use PT EP 13720737.9 Issued
NCI E-230-2011-1-NL-18 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use NL EP 13720737.9 Issued
NCI E-230-2011-1-GB-14 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use GB EP 13720737.9 Issued
NCI E-230-2011-1-ES-12 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use ES EP 13720737.9 Issued
NCI E-230-2011-1-CH-09 Vascular Endothelial Growth Factor Antagonist And Methods For Their Use CH EP 13720737.9 Issued
NCI E-200-1998-0-CA-38 Bisufran Derivatives Useful in Preventing the Emergence of Multidrug Resistnat HIV Strains and Treatment of HIV CA DIV 2872424 Expired
NIDCR E-105-2003-0-US-04 Avian Adenoassociated Virus and Uses Thereof US DIV 14/554,728 9238800 Expired PDF
NCI E-028-2015-0-US-01 Anti-Mutated KRAS T Cell Receptors US 62/084,654 Abandoned
NCATS E-214-2014-0-US-01 Small Molecule Aldehyde Dehydrogenase Inhibitors and Methods of Use Thereof US 62/084,830 Abandoned
NCI E-040-2012-0-CN-07 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen CN National Stage 201380027676.3 Abandoned
NIDDK E-011-2014-0-TW-03 Heterocyclic Compounds and Methods of Use Thereof TW ORD 103141004 Abandoned
NIAID E-170-2013-1-CA-03 CHIMERIC ANTIGEN RECEPTORS TO CONTROL HIV INFECTION CA National Stage 2930587 Issued
NICHD E-552-2013-0-BR-04 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE BR National Stage BR112016011997-5 Issued
NICHD E-552-2013-0-CA-05 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE CA National Stage 2930872 Issued
NICHD E-552-2013-0-MX-11 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE MX National Stage MX/a/2016/006774 Issued
NICHD E-552-2013-0-AU-03 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE AU National Stage 2014354839 Issued
NICHD E-552-2013-0-CN-06 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE CN National Stage 201480074046.6 Issued
NICHD E-552-2013-0-JP-10 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE JP National Stage 2016-554828 Issued
NIAID E-170-2013-1-AU-02 CHIMERIC ANTIGEN RECEPTORS TO CONTROL HIV INFECTION AU National Stage 2014352638 Issued
NIAID E-170-2013-1-EP-04 CHIMERIC ANTIGEN RECEPTORS TO CONTROL HIV INFECTION EP National Stage 14812376.3 Issued
NICHD E-552-2013-0-EP-08 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE EP National Stage 14812375.5 Issued
NICHD E-552-2013-0-BE-15 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE BE EP 14812375.5 Issued
NICHD E-552-2013-0-CH-16 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE CH EP 14812375.5 Issued
NICHD E-552-2013-0-GB-20 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE GB EP 14812375.5 Issued
NICHD E-552-2013-0-ES-18 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE ES EP 14812375.5 Issued
NICHD E-552-2013-0-SE-23 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE SE EP 14812375.5 Issued
NICHD E-552-2013-0-IT-21 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE IT EP 14812375.5 Issued
NICHD E-552-2013-0-DE-17 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE DE EP 14812375.5 Issued
NICHD E-552-2013-0-FR-19 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE FR EP 14812375.5 Issued
NICHD E-552-2013-0-NL-22 ADENO-ASSOCIATED VIRUS VECTORS FOR TREATMENT OF GLYCOGEN STORAGE DISEASE NL EP 14812375.5 Issued
NCI E-321-2003-0-AU-11 A Human Cytolytic T-Lymphocyte Epitope and its Agonist Epitope from the Non-Variable Number of Tandem Repeat Sequence of MUC-1 AU DIV 2014268156 Expired
NCI E-136-2012-0-US-07 High-Affinity Monoclonal Antibodies To Glypican-3 And Use Thereof US National Stage 14/403,896 9409994 Issued PDF